| # | Drug | Count |
|---|---|---|
| 0 | PACLITAXEL | 139 |
| 1 | PACLITAXEL (AIBUMIN-BOUND) | 132 |
| 2 | FULVESTRANT | 79 |
| 3 | GEMCITABINE HYDROCHLORIDE | 76 |
| 4 | BEVACIZUMAB | 74 |
| 5 | CAPECITABINE | 73 |
| 6 | GEMCITABINE | 68 |
| 7 | CYCLOPHOSPHAMIDE | 55 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 55 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 55 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IXABEPILONE | 31 | 0.0295 |
| 1 | VINORELBINE | 39 | 0.0056 |
| 2 | ERIBULIN MESYLATE | 11 | 0.0029 |
| 3 | FULVESTRANT | 79 | 0.0024 |
| 4 | ANASTROZOLE TABLETS | 45 | 0.0020 |
| 5 | IVOSIDENIB | 4 | 0.0018 |
| 6 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 17 | 0.0016 |
| 7 | EXEMESTANE | 33 | 0.0015 |
| 8 | GEMCITABINE HYDROCHLORIDE | 76 | 0.0014 |
| 9 | BODY CLEANSER | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 156 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 94 |
| 2 | Aromatase Inhibitor [EPC] | 82 |
| 3 | Estrogen Receptor Antagonist [EPC] | 79 |
| 4 | Kinase Inhibitor [EPC] | 75 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 74 |
| 6 | Alkylating Drug [EPC] | 56 |
| 7 | Platinum-based Drug [EPC] | 50 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 32 |
| 9 | mTOR Inhibitor Immunosuppressant [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 79 | 0.0019 |
| 1 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 4 | 0.0018 |
| 2 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 3 | Microtubule Inhibitor [EPC] | 156 | 0.0009 |
| 4 | Aromatase Inhibitor [EPC] | 82 | 0.0007 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 32 | 0.0004 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 74 | 0.0004 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 94 | 0.0003 |
| 9 | Alkylating Drug [EPC] | 56 | 0.0002 |